Site Search
Search Results
Legislative Action Needed to Reduce the Burden of Cancer on Buckeyes
Statement from American Cancer Society Cancer Action Network (ACS CAN) Government Relations Director Leo Almeida COLUMBUS, OHIO – “As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges legislators to prioritize passing legislation to ease the burden of cancer on Buckeyes. “ACS CAN calls on the legislature to increase access to biomarker testing, a game changer in the fight against cancer ... the right time,’ precision medicine has played a critical role in improving cancer outcomes. Despite its benefits, health insurance coverage of biomarker testing has not kept pace with innovations in treatment. “Furthermore, copay accumulator legislation unanimously passed the House ...
Advocates Hold Cancer Action Day at State House, Urging Lawmakers to Expand Access to Biomarker Testing & Address Affordability Concerns
CONCORD, NH —March 6, 2025— Earlier today, American Cancer Society Cancer Action Network (ACS CAN) volunteers rallied at the New Hampshire State House as a part of their annual Cancer Action Day advocating for several legislative proposals that aim to address the needs of patients across the cancer ... Specifically, the advocates urged support of a proposal to improve access to biomarker testing (SB 120) and legislation relative to insurance cost sharing calculations (SB 17). They also asked lawmakers to protect level funding for the state’s Tobacco Control & Cessation Program, the ...
California Assembly Committee Passes Legislation Requiring More Insurance Plans Cover Biomarker Testing Needed for Many Innovative Cancer Treatments
... Senate Bill 912 will enable more Californians to benefit from biomarker testing, a critical step in accessing precision medicine treatments that can lead to fewer side effects, improved survival, better quality of life and potentially lower costs for some cancer patients. But to determine if a patient will benefit from certain targeted therapies, doctors ... Ogden-Smith, California Legislative Director for the American Cancer Society Cancer Action Network (ACS CAN). “It’s imperative we dismantle cost barriers in order to address and help reduce health disparities.” Communities that have been under-resourced, including communities of ...
Senate Introduces Legislation to Increase Californians’ Access to Lifesaving Testing and Innovative Treatments
... Calif. — Today, State Senator Monique Limón (D-Santa Barbara) introduced Senate Bill 912 to increase access to biomarker testing, which can help determine the best treatment plan for a specific patient. The American Cancer Society Cancer Action Network (ACS CAN) and the University of California (UC) have teamed up to sponsor this important next step in ensuring cancer patients have access to precision medicine. The UC system ... coverage of biomarker testing more broadly, I have introduced SB 912. The bill will reduce barriers patients face when accessing timely care and cost of treatment. SB 912 will improve access to care, precision medicine, and will reduce overall healthcare costs by avoiding unnecessary ...